NASDAQ: EPRX
Eupraxia Pharmaceuticals Inc Stock Ownership - Who owns Eupraxia Pharmaceuticals?

Insider buying vs selling

Have Eupraxia Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EPRX insiders and whales buy or sell their stock.

EPRX Shareholders

What type of owners hold Eupraxia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scotia Capital Inc3.59%1,291,989$6.93MInstitution
Royal Bank Of Canada1.19%428,584$2.30MInstitution
Goldman Sachs Group Inc0.11%39,800$213.33kInstitution
Ubs Group Ag0.10%37,499$200.99kInstitution
Bank Of Montreal0.10%37,250$199.66kInstitution
Ingalls Snyder LLC0.10%37,200$199.39kInstitution
Jpmorgan Chase Co0.05%18,717$100.32kInstitution
Citadel Advisors LLC0.05%18,236$97.74kInstitution
Cibc World Market Inc0.04%15,000$80.40kInstitution
Bank Of America Corp0.03%12,559$67.32kInstitution

1 of 2

EPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EPRX5.48%0.00%
ASMB24.12%75.88%Net Buying
OABI44.84%26.84%Net BuyingNet Buying
RAPT30.45%69.55%
VYGR53.00%47.00%Net SellingNet Selling

Eupraxia Pharmaceuticals Stock Ownership FAQ

Who owns Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals (NASDAQ: EPRX) is owned by 5.48% institutional shareholders, 0.00% Eupraxia Pharmaceuticals insiders, and 94.52% retail investors. Scotia Capital Inc is the largest individual Eupraxia Pharmaceuticals shareholder, owning 1.29M shares representing 3.59% of the company. Scotia Capital Inc's Eupraxia Pharmaceuticals shares are currently valued at $6.93M.

If you're new to stock investing, here's how to buy Eupraxia Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.